How do immune cells shape type 1 diabetes? Insights from Mendelian randomization

Area of Science:

• Immunology
• Genetics
• Endocrinology

Background:

• The precise role of immune cells in the development of type 1 diabetes (T1D) remains incompletely understood.
• Investigating causal relationships between immune cell phenotypes and T1D is crucial for advancing therapeutic strategies.

Purpose of the Study:

• To employ Mendelian randomization (MR) to assess the causal effect of various immune cell phenotypes on type 1 diabetes (T1D).
• To identify specific immune cell markers associated with genetic susceptibility to T1D.

Main Methods:

• Utilized large-scale genetic datasets for immune cell phenotypes and T1D.
• Applied inverse variance weighted (IVW) as the primary MR analysis method.
• Assessed horizontal pleiotropy using MR-Egger and conducted heterogeneity and sensitivity analyses with Cochran's Q and leave-one-out methods.

Main Results:

• MR analysis identified seven immune cell phenotypes associated with increased genetic susceptibility to T1D.
• Significant associations included specific T cell subsets (EM DN, EM CD8br), CD28 expression, lymphocyte populations (IgD+CD38dim), monocyte CD80 expression, and plasmacytoid dendritic cell (pDC) characteristics (SSC-A, FSC-A).
• Sensitivity analyses confirmed the robustness of the findings, with minor heterogeneity noted for CD28 on CD28+CD45RA+CD8br T cells.

Conclusions:

• Seven distinct immune cell phenotypes demonstrate a causal association with increased genetic predisposition to type 1 diabetes (T1D).
• These identified immune cell markers provide novel targets for understanding T1D pathogenesis.
• The findings suggest potential new avenues for T1D drug development and therapeutic interventions.